Roswell Park Researchers Document Worse Outcomes for Black Patients With Early-Stage Breast Cancer
Analysis of treatment response among more than 100,000 people underscores need for personalized...
Read More
Tag: Immunotherapy
Novel Immunotherapy Approach at Roswell Park Shows Promise in Metastatic Triple-Negative Breast Cancer
Short-term regimen effectively ‘reprograms’ tumor prior to additional immunotherapy Phase 1...
Read More
Roswell Park Team Assesses Addition of Complement Inhibitor Drug to Immunotherapy for Ovarian Cancer
Study in patients with recurrent ovarian, fallopian-tube or peritoneal tumors aims to improve...
Read More
Roswell Park Investigators Reveal Changes to Immune Status in Patient Tumors After Radiation
Few prior studies have explored cell-level changes in irradiated patient tumors Study analyzed...
Read More
Roswell Park Researchers Uncover Clues to Immunotherapy Response in Patients with Recurrent Ovarian Cancer
Talk at SGO Conference on Women’s Cancer highlights importance of measuring both senescent and...
Read More
Roswell Park Presents ‘Highly Encouraging’ Phase 2A Results on SurVaxM Immunotherapy for Glioblastoma
Results of phase 2A single-arm trial assessing SurVaxM plus standard therapy highlighted in poster...
Read More
Roswell Park New Phase in Trial of Brain Cancer Immunotherapy
Roswell Park Opens Phase 2B Randomized Clinical Trial of Promising Brain Cancer Immunotherapy...
Read More
Troponin Monitoring Can Detect Myocarditis
Early Troponin Monitoring Can Help Detect Immunotherapy-Related Myocarditis Roswell Park research...
Read More
